Retatrutide is a triple agonist that activates GLP-1, GIP, and glucagon receptors simultaneously, whereas semaglutide targets only GLP-1 and tirzepatide targets GLP-1 and GIP
Common Side Effects Nausea Vomiting Diarrhea Constipation Decreased appetite Stomach discomfort or bloating Injection site reactions such as redness or mild swelling Less Common Side Effects Fatigue during the first few weeks Heartburn or acid reflux Headache Dizziness If side effects feel unmanageable at the Retatrutide starting dose, speak with your doctor before making any changes
Results vary
When to see a doctor, dermatologist or trichologist Your shedding is sudden, severe or accompanied by burning, itching or pain
The trial is a randomized, double-blind, placebo-controlled multicenter study to evaluate the safety, tolerability, pharmacokinetics, and weight loss efficacy